Literature DB >> 11562460

Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis.

Y Zhang1, H Wang, S Toratani, J D Sato, M Kan, W L McKeehan, T Okamoto.   

Abstract

We have reported that normal human salivary gland-derived epithelial cells exclusively express keratinocyte growth factor receptor (KGFR). In the process of malignant transformation of human salivary gland tumors, KGFR gene expression disappeared concomitantly with the de novo expression of the fibroblast growth factor receptor 1 (FGFR1) and FGFR4 genes. In the present study, we introduced wild-type KGFR cDNA or chimeric KGFR/FGFR1 cDNA, which encoded the extracellular domain of KGFR and the intracellular domain of FGFR1, into the HSY human salivary adenocarcinoma cell line. The KGFR tyrosine kinase suppressed the activity of FGF receptor substrate 2 (FRS2) and inhibited the growth of HSY by inducing differentiation and apoptosis in vitro and in vivo. Our results provided significant insight into the mechanism of KGFR tumor suppression and suggest that KGFR gene therapy might be a viable method of inhibiting human salivary adenocarcinoma growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562460      PMCID: PMC58730          DOI: 10.1073/pnas.191377098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Identification and assay of fibroblast growth factor receptors.

Authors:  M Kan; E G Shi; W L McKeehan
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation.

Authors:  Y R Hadari; H Kouhara; I Lax; J Schlessinger
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras.

Authors:  J K Wang; H Xu; H C Li; M Goldfarb
Journal:  Oncogene       Date:  1996-08-15       Impact factor: 9.867

4.  Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas.

Authors:  S G Diez de Medina; D Chopin; A El Marjou; A Delouvée; W J LaRochelle; A Hoznek; C Abbou; S A Aaronson; J P Thiery; F Radvanyi
Journal:  Oncogene       Date:  1997-01-23       Impact factor: 9.867

5.  Isolation and characterization of different molecular and chromatographic forms of heparin-binding growth factor 1 from bovine brain.

Authors:  W L McKeehan; J W Crabb
Journal:  Anal Biochem       Date:  1987-08-01       Impact factor: 3.365

6.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

7.  Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.

Authors:  S Feng; F Wang; A Matsubara; M Kan; W L McKeehan
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

8.  Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2.

Authors:  A Matsubara; M Kan; S Feng; W L McKeehan
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

Review 9.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

10.  Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera.

Authors:  W J LaRochelle; O R Dirsch; P W Finch; H G Cheon; M May; C Marchese; J H Pierce; S A Aaronson
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more
  27 in total

1.  Exogenous expression of caspase-14 induces tumor suppression in human salivary cancer cells by inhibiting tumor vascularization.

Authors:  Mengjie Wu; Isamu Kodani; Douglas Dickinson; Frank Huff; Kalu U E Ogbureke; Haiyan Qin; Senthil Arun; Rachel Dulebohn; Mohamed Al-Shabrawey; Amany Tawfik; Susan Prater; Jill Lewis; John Wataha; Regina Messer; Stephen Hsu
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

2.  Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.

Authors:  Xuegong Zhu; Sylvia L Asa; Shereen Ezzat
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

3.  Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma.

Authors:  Michael G Gartside; Huaibin Chen; Omar A Ibrahimi; Sara A Byron; Amy V Curtis; Candice L Wellens; Ana Bengston; Laura M Yudt; Anna V Eliseenkova; Jinghong Ma; John A Curtin; Pilar Hyder; Ursula L Harper; Erica Riedesel; Graham J Mann; Jeffrey M Trent; Boris C Bastian; Paul S Meltzer; Moosa Mohammadi; Pamela M Pollock
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

4.  Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.

Authors:  Zhen Zhen Zhao; Pamela M Pollock; Shane Thomas; Susan A Treloar; Dale R Nyholt; Grant W Montgomery
Journal:  Hum Reprod       Date:  2008-02-18       Impact factor: 6.918

5.  Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.

Authors:  Qi Zhao; Otavia L Caballero; Ian D Davis; Eric Jonasch; Pheroze Tamboli; W K Alfred Yung; John N Weinstein; Robert L Strausberg; Jun Yao
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

6.  Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.

Authors:  Xuegong Zhu; Sylvia L Asa; Shereen Ezzat
Journal:  Mol Endocrinol       Date:  2009-06-04

7.  Homology modeling and virtual screening studies of FGF-7 protein-a structure-based approach to design new molecules against tumor angiogenesis.

Authors:  Rajender Vadija; Kiran Kumar Mustyala; Navaneetha Nambigari; Ramasree Dulapalli; Rama Krishna Dumpati; Vishwanath Ramatenki; Santhi Prada Vellanki; Uma Vuruputuri
Journal:  J Chem Biol       Date:  2016-06-18

8.  Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.

Authors:  Xuegong Zhu; Katie Lee; Sylvia L Asa; Shereen Ezzat
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 9.  Fibroblast growth factor signalling: from development to cancer.

Authors:  Nicholas Turner; Richard Grose
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

10.  Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.

Authors:  Heike Steiling; Marcus Mühlbauer; Frauke Bataille; Jürgen Schölmerich; Sabine Werner; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.